2081. Building a Decision Tree with Serial Serology Measurements Improves Classification in a Flavivirus Co-circulation Region. (26th November 2018)

• Record Type: Journal Article
• Authors: Lumbard, Keith; Arteaga Cabello, Fernando J; Gouel-Cheron, Aurelie; Belaunzarán, Francisco; Nájera-Cancino, Gabriel; Caballero-Sosa, Sandra; Rincón-León, Héctor; Del Carmen Ruis Hernandez, Emilia; Cervantes, Pilar Ramos; Lourdes Guerrero, M; Beigel, John; Trujillo-Murillo, Karina; Pedraza, Gustavo; Sepulveda, Jesús; Escobedo-Lopez, Kenia Melina; Mora-Suarez, Nora K; Reyes-Romero, Monica; Ibarra-González, Violeta; Marínez-Lopez, Julia; Ruiz-Palacios, Guillermo; Hunsberger, Sally
• Is Part Of: Open forum infectious diseases. Volume 5(2018)Supplement 1
• Page Start: S608
• Page End: S609
• Publication Date: 2018-11-26
• Subjects: Communicable diseases -- Periodicals; Medical microbiology -- Periodicals; Infection -- Periodicals; 616.9
• DOI: 10.1093/ofid/ofy210.1737
• Languages: English
• ISSNs: 2328-8957

Abstract

Abstract: Background: RT-PCR (reverse transcriptase polymerase chain reaction) is often considered the "gold standard" for diagnosis of Zika Virus (ZIKV) infection; however, it has been shown to have low sensitivity. A possible remedy is to study ZIKV-specific IgG (ZsIgG) and IgM (ZsIgM) antibodies. However, the in vitro cross-reactivities of Dengue virus (DENV) and ZIKV-specific antibodies are well known, leading to diagnostic difficulties in an area with co-circulation of the two viruses. Our goal was to use Zika and Dengue serologic assays to build a classification model that improves upon the PPV of commercial kits while maintaining sensitivity. Methods: We conducted a prospective longitudinal study in Southern Mexico where DENV and ZIKV co-circulation occurs ( NCT02831699 ). Patients were included in two cohorts: a cohort of subjects presenting with a febrile rash meeting WHO/PAHO Zika case definition and a household cohort. After signed consent, all subjects enrolled were evaluated on study-visit Days 0, 3 and 7 (for fever rash cohort) and 28. We considered a subject "true positive" for ZIKV or DENV if RT-PCR positive at any time point. The healthy household cohort (with no positive RT-PCR) was considered "true negatives." We fit a statistical decision tree taking as inputs serial serology measurements and outputting a predicted disease category. Funded in part by the NCI Contract No. HHSN261200800001E. Funded in part by the Mexican Ministry of Health. Results: As of March 2018, we have 32 subjects in the Zika PCR+ group, 32 in the Dengue PCR+ group, and 68 in the household group. Our decision tree (Figure 1) achieved PPV of at least 90% on all three disease categories, while maintaining sensitivity above 50%. The highest PPV achieved by the kit manufacturer recommended cutoffs while maintaining a sensitivity of at least 10% on Zika PCR+ subjects is 30/114 (26%), and for Dengue PCR+ subjects is 21/30 (70%). Conclusion: Using serology data in a statistical decision tree improves the PPV exhibited by the kit manufacturer recommendations while still maintaining respectable sensitivity. Physicians in regions with co-circulating flaviviruses should be aware of the pitfalls of using only RT-PCR or using pre-established commercial cutoffs in the serology kits for diagnosis. Disclosures: All authors: No reported disclosures.